Manufacturing complications and the absence of an indemnification agreement have caused delays in the delivery of AstraZeneca COVID-19 vaccines to the Philippines.
The COVAX Facility is now expected to start delivering AstraZeneca vaccines late in February.
The Philippines is scheduled to receive between 5,500,800 and 9,290,400 doses of AstraZeneca vaccines through the COVAX Facility in the first half of the year.
Additionally, the delivery of 117,000 doses of Pfizer vaccines may be further delayed due to sub-zero transportation and logistics requirements.
Presidential spokesperson Harry Roque stated that the COVAX Facility has given notice of potential delays for the Pfizer vaccines.
The delivery of Sinovac vaccines might also be delayed as the company awaits emergency use authorization from the Philippine FDA before sending supplies.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.




